https://ranolazineinhibitor.co....m/vestibular-excitem
On univariable evaluation, Eastern Cooperative Oncology Group (ECOG) overall performance status (PS) ended up being associated with inferior PFS (hazard ratio [HR], 1.45; 95% confidence period [CI], 1.03-2.05; P = .03) and OS (HR, 1.76; 95% CI, 1.17-2.64; P = .007). Greater CIRS (CIRS ≥7 or CIRS-3+) was related to inferior OS (HR, 2.12; 95%, CI, 1.06-4.22; P = .03) and a nonsignificant trend in even worse PFS (HR, 1.45; 95% CI, .87-2.44; P = .16). In multivariable analyses, CIRS ≥7 or CIRS